A Predictive Model For Determining The Efficacy Of Multiple Doses Of Qge031 (ligelizumab) Versus Omalizumab And Placebo In Inhibiting The Allergen-Induced Early Asthmatic Response Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Gauvreau, Gail
  • Boulet, L-P
  • Leigh, R
  • Cockcroft, DW
  • Davis, BE
  • Mayers, I
  • FitzGerald, J
  • Dahlen, B
  • Watson, RM
  • Milot, J
  • Swystun, V
  • Hui, L
  • Lantz, A-S
  • Bowen, M
  • Arm, J
  • Maahs, S
  • Meiser, K
  • Lowe, P
  • Skerjanec, A
  • Carlsten, C
  • Strandberg, K
  • Killian, Kieran
  • Laviolette, M
  • Drollmann, A
  • O'Byrne, Paul

publication date

  • January 1, 2015